Eli Lilly and Company (LLY)

55.02 -0.88  -1.57%  May 20, 8:00PM
Add to Watchlists Create an Alert

Eli Lilly and Company SG&A Expense Quarterly:

1.652B for March 31, 2013
View Full Chart

Eli Lilly and Company SG&A Expense Quarterly Chart

    Eli Lilly and Company Historical SG&A Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 1.652B
    Dec. 31, 2012 1.978B
    Sept. 30, 2012 1.757B
    June 30, 2012 1.931B
    March 31, 2012 1.848B
    Dec. 31, 2011 2.133B
    Sept. 30, 2011 1.918B
    June 30, 2011 2.043B
    March 31, 2011 1.786B
    Dec. 31, 2010 1.989B
    Sept. 30, 2010 1.695B
    June 30, 2010 1.755B
    March 31, 2010 1.614B
    Dec. 31, 2009 1.953B
    Sept. 30, 2009 1.702B
    June 30, 2009 1.708B
    March 31, 2009 1.529B
    Dec. 31, 2008 1.727B
    Sept. 30, 2008 1.649B
    June 30, 2008 1.700B
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About SG&A Expense

    SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

    The details of how SG&A expenses are calculated vary widely from company to company, so YCharts recommends looking at the annual report (10-k) an investor is interested in dissecting this number further.
    Learn More

    Get data for

    LLY SG&A Expense Quarterly Benchmarks

    Companies
    Sanofi 2.729B
    Pfizer 3.585B
    Merck 2.987B

    LLY SG&A Expense Quarterly Rankings

    Overall 98th percentile
    130 of 8002
    Sector 98th percentile
    13 of 684 in Healthcare
    Industry 85th percentile
    8 of 54 in Drug Manufacturers - Major

    LLY SG&A Expense Quarterly Range, Past 5 Years

    Minimum 1.529B Mar 2009
    Maximum 2.133B Dec 2011
    Average 1.803B